Skip to content

The Yellow Card scheme has recently introduced NHS login, allowing users to log into their Yellow Card scheme account with existing credentials. Please find further information using the link below.

NHS login

YellowCard
Making medicines and medical devices safer

E-cigarettes

YC ECigarette

If you have an adverse reaction or safety concern about a nicotine-containing e-cigarette (also known as a vape) and/or e-liquid you should report this to our Yellow Card scheme. 

What is an e-cigarette and e-liquid?

E-cigarettes and accompanying e-liquids are nicotine containing vaping products. It is a device that heats up the liquid, so that the user inhales the nicotine as a vapour, instead of smoke. They are available to purchase for people over 18 years, however they are not recommended for people who do not currently smoke.   

Adverse reactions to e-cigarettes and e-liquids

An adverse reaction is when the resulting effect causes harm (this can be both physical or mental). 

Safety concerns related to e-cigarettes and e-liquids

  • Adverse reactions could also be the result of defective or fake e-cigarettes or e-liquids (one that is not authentic). 

  • A defective e-cigarette (and/or e-liquid) is a product that is not working properly or not to the manufacturer’s specifications. 

  • A fake e-cigarette (and/or e-liquid) is a product that tries to pass off as a genuine authorised e-cigarette (and/or e-liquid). 

If the defective or maybe fake e-cigarette and/or e-liquid is causing an adverse reaction or is a safety concern report this to the MHRA Yellow Card scheme. 

Why report side effects to the Yellow Card scheme?

Everyone has a different genetic makeup and therefore it is very difficult to predict whether an individual will experience a side effect. Whether you are a healthcare professional or a member of the public, you can help others by reporting adverse reactions which you or your patients experience to the MHRA Yellow Card scheme. Reports help us gain a better understanding of e-cigarette and e-liquid interactions and safeguard patients whole through vigilant monitoring. 

Find out more about the Yellow Card scheme, including how to report.